chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ARM WAS SORE FROM TIME OF SHOT UNTIL 12/25/20 AM. ON 12/29/20 AT 11 PM EMPLOYEE NOTED ITCHING TO INJECTION SITE. ARM WAS ALSO SWOLLEN AND RED. THIS HAS PROGRESSED TO MUSCCLE PAIN TO ENTIRE RIGHT ARM. EMPLOYEE CALLED PCP WHO OFFEREN NO ADVICE. EMPLOYEE THEN CALL INFECTION PREVENTION NURSE AT HER EIMPLOYMENT (MEDICAL CENTER). IP CONSULTED WITH PHARMACIST WHO ADVISED EMPLOYEE TAKE BENADRYL. IP REVIEW SIGNS TO WATCH FOR-ANAPHYLAXIS AND INFECTION. WAS ADVISED TO COME TO THE ED IF SYMPTOMS WORSEN.
30 minutes after first dose I began getting pins and needles sensations in my arms and hands. 40 minutes after first dose I began feeling numbness in my face. These sensations came and went throughout the rest of the day. The facial numbness came and went throughout day two as well. Then 12 hours after the first dose, pain in the injection arm began to radiate throughout my arm down into my hand and then up into my neck and shoulders. I was not able to raise my arm on day two and had painful headaches and neck and back pain for the next 3 days. These effects seemed to resolve after about day three.   In Feb. I got the second dose -- no effects for the first two days and then about 50 to 60 hours after the second dose I began feeling very unwell and weird as if I had been poisoned. I began feeling fatigue, nausea, headaches, body aches, brain fog. These lasted for about 12 or 13 days. Around day 7 or so symptoms were getting worse with night sweats (no registered fever) and heart palpitations that came and went. The last night of symptoms I had a sudden onset of severe abdominal pain that lasted about 4 hours, from about 10pm to 2am or so. I would say it was a level 8 or 9 out of 10. I considered going to the ER but then the pain subsided after about 4 hours and on day 13 I seemed to be OK although  a year later I still get some headaches and heart racing and fluttering, a few times a week.
laid  in bed for two days; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (laid  in bed for two days) and FATIGUE (Tiredness) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 032M20A) for COVID-19 prophylaxis.     Concomitant products included SILDENAFIL and OMEPRAZOLE for an unknown indication.   On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2022, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced ILLNESS (laid  in bed for two days) and FATIGUE (Tiredness). In April 2021, ILLNESS (laid  in bed for two days) and FATIGUE (Tiredness) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported.   This case was linked to MOD-2022-663250, MOD-2022-663266 (Patient Link).
Within a couple of weeks, experienced extreme fatigue and body aches to the point I could hardly function.  Went to the doctor and have since been diagnosed with an autoimmune disease.  So far treatment for the autoimmune disease has not been effective and am still experiencing extreme side effects.
DEVELOPED CHILLS, BODY ACHES, FLU LIKE SYMPTOMS FOR 2 HOURS ONE DAY AFTER THE VACCINATION, TOOK EXCEDRIN AND IT GOT BETTER
Subject came to the research site and verbalized being pregnant since 17/DEC/2021. Subject refused to receive 2nd shot of the Moderna COVID-19 vaccine at this time.  Estimated Date of Delivery is on August 28, 2022. She verbalized that she is about 6-7 weeks pregnant when she was seen at site.
Breakout of lesions on left forearm.   This was the arm I was vaccinated in.    This was not "Covid Arm" as has been described.   This seemed more like hard  painful pimples forming under the skin.    Around 15 lesions presented themselves and took several weeks to resolve.   There is some scarring with these and rough skin where the lesions presented themselves.   I have had ingrown hairs or other normal skin issues but this was very odd and the only thing I can link it to was getting the Covid vaccination.      I have since read that there are altered levels of C8 t cells which may allow other issues such as past chicken pox, shingles,  or other issues to present themselves.   Who knows,  we are experimenting on ourselves after all.
Armpit swollen; Armpit swollen and pain; lump under armpit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An 11-year-old male patient received BNT162b2 (BNT162B2), on 21May2022 at 16:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 11 years intramuscular, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose 2; lot number: FK5127, administrator route: Intramuscular, administration time: 01:00 PM, vaccine location: Left arm), administration date: 19Dec2021, when the patient was 10-year-old, for Covid-19 immunization; BNT162b2 (Dose 1; lot number: FK5127, administrator route: Intramuscular, administration time: 01:00 PM, vaccine location: Left arm), administration date: 28Nov2021, when the patient was 10-year-old, for COVID-19 Immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 22May2022 at 07:00, outcome "not recovered", described as "Armpit swollen"; AXILLARY PAIN (non-serious) with onset 22May2022 at 07:00, outcome "not recovered", described as "Armpit swollen and pain"; AXILLARY MASS (non-serious) with onset 22May2022 at 07:00, outcome "not recovered", described as "lump under armpit". Therapeutic measures were not taken as a result of lymphadenopathy, axillary pain, axillary mass.  Additional Information: The patient had no known allergies. The patient did not received any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Other medications in two weeks: No; other medical history: No.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
patient had arm soreness, sore arm from COVID 19 booster shot.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (patient had arm soreness, sore arm from COVID 19 booster shot.) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Secondary pulmonary arterial hypertension since 09-Sep-2020. Concomitant products included TREPROSTINIL SODIUM (TYVASO) from 09-Sep-2020 to an unknown date for Secondary pulmonary arterial hypertension, RIOCIGUAT (ADEMPAS), APIXABAN (ELIQUIS) and DILTIAZEM HYDROCHLORIDE (DILTIAZEM [DILTIAZEM HYDROCHLORIDE]) for an unknown indication.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (patient had arm soreness, sore arm from COVID 19 booster shot.). At the time of the report, PAIN IN EXTREMITY (patient had arm soreness, sore arm from COVID 19 booster shot.) outcome was unknown. Not Provided          No treatment information was provided.
Sore left arm; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm left on 20Apr2021 at 06:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and blood pressure high. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medication within two weeks of vaccination. On 20Apr2021 at 06:15, the patient experienced sore left arm. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with an unspecified medication for an unknown indication from an unknown date and unknown if ongoing. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore left arm was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 24-MAR-2014, the patient was vaccinated with ZOSTAVAX (dose, frequency and lot# not reported) which underwent a supported temperature excursion - was exposed to 8C for 48 hrs as well as the 1C for 72 hours on unspecified dates. No adverse effects were reported. Additional information has been requested.
Patient said she was very ill for 4 to 5 days and just felt a little better after 1 week. She had swollen arms, fever that she almost chip her teeth, nausea, vomiting, dizziness with bloody red eyes and increase heart rate. She was so weak that she can barely have enough coordination and energy to use her inhaler.  Her family though she had COVID but she knew it was the shot as she felt the symptoms within 3 hours after receiving the vaccines.
Fever/chills/muscle aches/GI symptoms. Pain in shoulder, painful to rotate.
low grade fever/joint pain/muscle pain lasting  up to today 8/13/2021- fatigue/headache/ red-fist size swelling at injection site remain.
flu like symptoms; fatigue; Fever of 101.4 by the morning; significant full body aches; skin tenderness to the touch all over; headache; soreness at the injection site; This is a spontaneous report from a Non-contactable consumer (patient). A 36- year-old female received second dose of bnt162b2 (BNT162B2, Solution for injection, Lot: EW0179) via unspecified route of administration on 21May2021 at 09:30 AM (36-year-old age at vaccination) in right arm for COVID-19 immunization in Workplace clinic. Medical history and concomitant medications were not reported. patient previously took first dose of bnt162b2 (lot: ER8736) on 30Apr2021 09:00 am in right arm for Covid-19 immunization. No known allergies were reported. No other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination patient not diagnosed with COVID-19 neither since the vaccination patient been tested for COVID-19. After the first shot had mild hot flash like symptoms and soreness at injection site. On 21May2021, after the second shot (9:30 am) about 12 hours after receiving the shot had onset of flu like symptoms, fatigue (9:30 pm). Fever of 101.4 by the morning and significant full body aches, skin tenderness to the touch all over and headache. Were more than moderate symptoms but not so severe as I sought additional medical attention. This was in addition to soreness at the injection site. Symptoms subsided after 2 full days. Received her shot on a Friday morning and did not start to feel near normal until Sunday evening.No treatment was received by patient in response to the events. Outcome of the event soreness at the injection site was unknown and for remaining events it was recovered on 23May2021.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a lawyer regarding a case in litigation concerning an adult patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On or about 01-SEP-2014, the patient was inoculated, in a hospital, with a dose of ZOSTAVAX as recommended for routine adult health maintenance and for the long-term prevention of shingles (strength, route, anatomical location, dose number, lot/batch # and expiration date were not reported). On or about 01-APR-2016, the patient was treated by physicians for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. The vaccine did not prevent shingles as intended (vaccination failure), and the patient subsequently contracted a persistent strain of herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages (injury), and required extensive medical care and treatment. As a further proximate result, the patient had suffered and would continue to suffer significant medical expenses, and pain and suffering (emotional distress), and other damages (injury). The outcome of vaccination failure, herpes zoster, emotional distress, injury and pain was unknown. The reporter considered the events to be related to ZOSTAVAX.
High fever / chills / body aches / joint aches / headache / high blood pressure / high heart rate. Woke up in pool of sweat
Knee and overall joint swelling that lasted for about a month after the vaccine. Daily tasks became painful and athletic activity was severely limited
Patient received her Pfizer booster on 11/18/21 at around 11:15 am. About 5 minutes after injection, patient began to experience 10/10 chest tightness across her entire chest, with trouble catching her breath. Patient was transported to the gurney and initial vital signs were 156/81, HR 91, 99% on RA. Patient was observed for an additional 30 minutes.   At 11:55 VS: 116/74 HR 73 100% on RA. Patient states chest discomfort had improved but was still present at 4/10. She states she did not experience any issues or anxiety with previous doses of Pfizer. Patient was transported to ED via wheelchair for further evaluation.
From initial information received on Aug 31 2004 from a registered regarding an adverse event, it was reported that a four year old female patient received a Tripedia vaccination, lot number U1258BA, administered intramuscularly in the left thigh, an IPOL vaccination, lot number X3682, administered subcutaneously in the left thigh, and a MMR vaccination, lot number 0812N administered subcutaneously in the right thigh on Aug 24 2004 at 8:00pm. The next day, the patient developed a large erythematous reaction at the site of the Tripedia injection with blistering. It was reported that it look like a second decree burn or bullous impetigo. The patient recovered from these events. From additional information received on Oct 5 2004 from a health care professional, it was reported that the patient has three siblings and the vaccines administered were purchased with public funds. No further information is anticipated, this case is considered closed.
ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 11/30/2022 ESRD (END STAGE RENAL DISEASE) ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 11/30/2022 SEPTICEMIA DUE TO CENTRAL VENOUS CATHETER, INIT ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 11/30/2022 ANEMIA DUE TO CKD ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 11/30/2022 ESRD (END STAGE RENAL DISEASE) ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 11/30/2022 HEMODIALYSIS CATHETER INFECTION, INIT ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 11/30/2022 HYPOGLYCEMIA
Shingles; This case was reported by a physician via sales rep and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 30 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. Approximately, a month post first dose, the patient experienced shingles.
This student had COVID (presumed delta) in  mid December 2021. Her school required a booster to return in January 2022 if the students were eligible.  She got the booster as she was eligible per CDC guidelines.  Her roommates and she all had colds in early March of 2022. Her roommates got better, but she did not. After a weeklong hospital stay, she was diagnosed with adult onset stills disease.  It is affecting her everyday life almost a year later. It affected her heart, her liver and her immune system. She is now on lifelong medications and is immunosuppressed by them.
Severe chills (I shook uncontrollably for 12 + hours), low fever (highest was 100.3), extreme headache (worst Ive ever had, lasted approx 24 hours ),  nausea,  body aches, severe soreness of left arm (injection site)
on 4/4/21 patient started vomiting, fever, chills, aches, diarrhea- patient got tested for COVID 4/5/21 and COVID POSITIVE
Fever to 103.5 48hrs after H1N1 (inactivated) vaccine administered.
Pt had Varicella booster 4-29-14 and developed cough, fever, congestion and vesicular rash on (L) arm today later - now with zoster rash on (L) flank and (L) arm.
Approximately 12 hours after receiving the vaccine I experienced severe chills and couldn't get warm. I didn't take my temperature. The chills lasted approximately 5-6 hours. The day after receiving the vaccine I experienced fatigue and minor muscle aches.
No adverse event, reporting that she got Pfizer for the first shot. Moderna was her second shot.
Had a stroke; This is a spontaneous report from a contactable consumer via Pfizer-sponsored programs. A male patient (reporter's husband) of an unspecified age received first single dose of BNT162B2 (Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration on an unspecified date for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first dose of Covid vaccine on an unspecified date (Friday) at 12:35 PM, and had a stroke on Saturday morning at 10:30AM and was confined at the hospital (date/s unspecified) at the time of reporting. Reporter asked if there was any correlation or any fact sheets available with the vaccine and the stroke that happened to the patient. The outcome of the event was unknown.   Information about lot number and expiry date for the suspect product will be requested in follow-up attempts.
side effects experienced: none; inappropriate schedule of vaccine administration; This spontaneous report has been received from a lawyer via a Fact Sheet from a case in litigation for zoster vaccine live (ZOSTAVAX) (MARRS #1807USA004932), concerning a 66 year-old female patient. Before vaccination with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown), the patient received zoster vaccine live (ZOSTAVAX) (with experienced side effects of redness, hot to touch skin, swelling) and unspecified influenza (flu) vaccine. The patient's medical history included chicken pox (never received a chicken pox vaccine). The patient had never in the past smoked or used tobacco products. On 12-MAR-2017, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (reported as pneumonia vaccine; dose, anatomical location, route of administration, lot number and expiration date were not reported) for prophylaxis. Another doses of suspect vaccine were administered to the patient on 18-APR-2018 and 29-SEP-2018 (inappropriate schedule of vaccine administration). None (also reported as not applicable, n/a) side effects experienced. The pt's other reported vaccinations included: unspecified tetanus vaccine, in 2018 (reporter did not recall specific dates), unspecified influenza vaccine in 2020, and unspecified Coronavirus disease (COVID) vaccine in 2021.  This is one of three reports regarding the same patient.; Sender's Comments:  US-009507513-2202USA003492: US-009507513-1807USA004932:
23 hours after my 2nd dose, I'm experiencing itching at the injection site and it feels warm to the touch. It is also tender and hard to the touch. I have not taken any medications for the itching. But I may take one Benadryl closer to bedtime.
I have had both the doses of the Pfizer vaccine - 1st dose 03/31/2021- 2nd dose 04/21/2021 ( Wednesday) 8.00 PM; On saturday 04/24/2021 about 10.00 PM I saw rash on my face (mainly cheeks) and a little on my nect. I took Zyrtec and the rash subsided in an hour or so; Sunday (04/25/2021) Evening simila rash came back and I took one Zyrtec at 6.00 PM; Monday 4/26 morning slight rash & itchiness is there; other symptoms after the shot are Sore Arm and pain in the underam (same arm as the shot)
10-17-06. Chills, fever, severe heradache, arm sore. Seen by PCP. 10-19-06. Rash, right arm--injection site. Scattered erythema right, slightly raised. No sign of cellulitis---Senn by an NP. Ultracet for headache and arm pain.
The day after shot it looked like there was an area under the skin that was holding fluid. Then two days after my shot my arm looked like it had a hive about 2x3 inches.  It was red, swollen, hot and painful. I took Sudafed for that day and the next.  I also iced it but only on 2nd day after shot.  Today, 6 days after, it is no longer swollen but still slightly red, and somewhat hot and  painful to the touch. It looks like a giant "birth mark" and still looks a bit like the vaccine pooled in that area under my skin.  Arm still sore.
Patient developed a rash on the right side of abdomen 3 days after 1st vaccination.  Rash has persisted for and not resolved.
About 4 pm, pt was at a restaurant, felt lightheaded, and was trembling. She stood and passed out. Upon awakening pt kept repeating herself over and over. Has hx of absence sz , cut off DEPAKOTE x 3-4 years. Says she feels like she had a sz.  9/29/09 PCP medical records received DOS 8/5/2009. Assessment: Syncope. Call from patient's mother. Patient felt light headed, stood and fainted. Kept repeating herself.
Red raised circle around injection site. Itchy. No other symptoms. Just noticed circle stew days ago.
patient reported reaction similar to when a patient eats chickpeas and sesame seeds; nausea; trouble swallowing/similar to when a patient eats chickpeas and sesame seeds; fatigue; This case was reported by a nurse via call center representative and described the occurrence of allergic reaction in a 67-year-old male patient who received Herpes zoster (Shingrix) (batch number C47FY, expiry date 16th September 2022) for prophylaxis.   Concurrent medical conditions included food allergy (patient had reaction to chickpeas and sesame seeds).   On 6th October 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 6th October 2020, 1 hr after receiving Shingrix, the patient experienced allergic reaction, nausea, swallowing difficult and fatigue. On 6th October 2020, the outcome of the nausea, swallowing difficult and fatigue were recovered/resolved. On an unknown date, the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the allergic reaction, nausea, swallowing difficult and fatigue to be related to Shingrix.  Additional details were reported as follows: The patient received the dose and one hour later the patient reported reaction similar to when a patient eats chickpeas and sesame seeds. Patient reported trouble swallowing, fatigue and nausea, and all symptoms were resolved within a few hours.  Patient did not need to use Epipen.
Heart racing  and throat swelling 45 minutes after vaccine and two days after. Symptoms were mild
Started on April 1 I was hurting in m y grove area, Friday April 2 I went to the clinic I had my shot at.  They did a chest extra  to make sure I didn?t, have a blood clot. When home on Saturday I could hardly walk and get up on my own. It would rotate to both hands and wrist couldn?t bend my fingers. Went to Dr took labs if need contact physian. Went to ER twice  and gave me a steroid shot. Gave me pain medicine and medpack